Efficacy and safety of praziquantel for the treatment of human schistosomiasis during pregnancy: a phase 2, randomised, double-blind, placebo-controlled trial

Summary Background Despite WHO recommendations to offer pregnant women treatment with praziquantel, many nations continue to withhold treatment, awaiting data from controlled trials addressing safety and efficacy. The objectives of this study were to assess whether treatment of pregnant women with s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet infectious diseases 2016-02, Vol.16 (2), p.199-208
Hauptverfasser:	Olveda, Remigio M, MD, Acosta, Luz P, PhD, Tallo, Veronica, PhD, Baltazar, Palmera I, MD, Lesiguez, Jenny Lind S, MD, Estanislao, Georgette G, MD, Ayaso, Edna B, MD, Monterde, Donna Bella S, MD, Ida, Antonio, MD, Watson, Nora, PhD, McDonald, Emily A, PhD, Wu, Hannah W, PhD, Kurtis, Jonathan D, Prof, Friedman, Jennifer F, Prof
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Age Allergies Anthelmintics - administration & dosage Anthelmintics - adverse effects Birth weight Birth Weight - drug effects Blood Breastfeeding & lactation Congenital defects Double-Blind Method Drug dosages Female Fetus - drug effects Gestational Age Humans Infant, Newborn Infections Infectious Disease Infectious diseases Inflammation Laboratories Morbidity Philippines Praziquantel - administration & dosage Praziquantel - adverse effects Pregnancy Safety Schistosomiasis Schistosomiasis - drug therapy Studies Toxicology Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!